P2RY13, a purinergic receptor, has been linked to a favorable prognosis in patients with lung cancer; however, the purinergic receptor P2RY13 is not linked to tumor recurrence53 In the sciatic nerve transcriptome, P2RY13 is enriched and well expressed.54 Here, P2RY1 is linked to neoplasm.